GR3025257T3 - Quinoxalinedione derivatives as eaa antagonists. - Google Patents
Quinoxalinedione derivatives as eaa antagonists.Info
- Publication number
- GR3025257T3 GR3025257T3 GR970402894T GR970402894T GR3025257T3 GR 3025257 T3 GR3025257 T3 GR 3025257T3 GR 970402894 T GR970402894 T GR 970402894T GR 970402894 T GR970402894 T GR 970402894T GR 3025257 T3 GR3025257 T3 GR 3025257T3
- Authority
- GR
- Greece
- Prior art keywords
- chr
- alkyl
- hydrogen
- eaa antagonists
- quinoxalinedione derivatives
- Prior art date
Links
- 239000003194 amino acid receptor blocking agent Substances 0.000 title 1
- SEPKUNXLGWMPHL-UHFFFAOYSA-N quinoxaline-2,3-dione Chemical class C1=CC=CC2=NC(=O)C(=O)N=C21 SEPKUNXLGWMPHL-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- OZDAOHVKBFBBMZ-UHFFFAOYSA-N 2-aminopentanedioic acid;hydrate Chemical compound O.OC(=O)C(N)CCC(O)=O OZDAOHVKBFBBMZ-UHFFFAOYSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 108010011562 aspartic acid receptor Proteins 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A compound having the formulaor a pharmaceutically acceptable salt thereof whereinR is hydrogen or hydroxy;R<1 >is hydrogen,alkyl,arylalkyl,(CH2)nOH, or(CH2)nNR<7>R<8>;R<5 >and R<6 >are each independentlyhydrogen,halogen,NO2,CN,CF3,SO2NR<7>R<8>,PO3R<9>R<10>,alkyl,alkenyl,alkynyl,(CH2)nCONR<7>R<8>,(CH2)nCO2R<10>,NHCOR<11>,A is a ring formed by the following:a-NR<12>-CHR<13>-CHR<14>-b,a-CHR<13>-CHR<14>-NR<12>-b,a-CHR<13>-NR<12>-CHR<14>-b,a-CHR<14>-CH2-NR<12>-CHR<13>-b,a-CHR<13>-NR<12>-CH2-CHR<14>-b,a-CH2-CH2-CHR<13>-NR<12>-b,a-NR<12>-CHR<13>-CHR<12>-CH2-CH2-b,a-CH2-CH2-NR<12>-CH2-CH2-b,a-CH2-CH2-CH2NR<12>-CH2-b,a-CH2-NR<12>-CH2-CH2-ba-CH2-CH2-CH2-CH2-NR<12>-b,a-NR<12>-CH2-CH2-CH2-CH2-b,The compounds are useful in the treatment of disorders responsive to the blockade of glutamic and aspartic acid receptors.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96015792A | 1992-10-13 | 1992-10-13 | |
| US3433293A | 1993-03-22 | 1993-03-22 | |
| US12477093A | 1993-09-24 | 1993-09-24 | |
| PCT/US1993/009667 WO1994009000A1 (en) | 1992-10-13 | 1993-10-08 | Quinoxalinedione derivatives as eaa antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3025257T3 true GR3025257T3 (en) | 1998-02-27 |
Family
ID=27364627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR970402894T GR3025257T3 (en) | 1992-10-13 | 1997-11-05 | Quinoxalinedione derivatives as eaa antagonists. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6703391B2 (en) |
| EP (1) | EP0664807B1 (en) |
| JP (1) | JPH08502483A (en) |
| AT (1) | ATE157977T1 (en) |
| AU (1) | AU680632B2 (en) |
| DE (1) | DE69313866T2 (en) |
| DK (1) | DK0664807T3 (en) |
| ES (1) | ES2109516T3 (en) |
| GR (1) | GR3025257T3 (en) |
| WO (1) | WO1994009000A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843945A (en) * | 1993-05-13 | 1998-12-01 | Neurosearch A/S | AMPA antagonists and a method of treatment |
| WO1994026747A1 (en) * | 1993-05-13 | 1994-11-24 | Neurosearch A/S | Ampa antagonists and a method of treatment therewith |
| EP0705834A1 (en) * | 1994-07-27 | 1996-04-10 | Ciba-Geigy Ag | Quinoxaline-2,3-diones with an azaheterocyclic fused ring |
| EP0705835A1 (en) * | 1994-09-01 | 1996-04-10 | Ciba-Geigy Ag | Quinoxalic-2,3-diones with an oxa or thiaheterocyclic fused ring |
| US5801174A (en) * | 1994-09-14 | 1998-09-01 | Neurosearch A/S | Fused indole and quinoxaline derivatives, their preparation and use |
| AU687255B2 (en) * | 1994-09-14 | 1998-02-19 | Neurosearch A/S | Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| AU4423496A (en) | 1995-03-14 | 1996-10-02 | Warner-Lambert Company | Novel glutamate (ampa/kainate) receptor antagonists: n-substituted fused azacycloalkylquinoxalinediones |
| AU3571997A (en) * | 1996-08-01 | 1998-02-25 | Warner-Lambert Company | Novel glutamate receptor antagonists: fused cycloalkyl quinoxalinediones |
| WO2002014276A1 (en) * | 2000-08-10 | 2002-02-21 | Tanabe Seiyaku Co., Ltd. | Benzoylaminoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof |
| WO2002014277A1 (en) * | 2000-08-10 | 2002-02-21 | Tanabe Seiyaku Co., Ltd. | Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof |
| DE10121215A1 (en) * | 2001-04-30 | 2002-10-31 | Merck Patent Gmbh | Dihydro-imidazo [4,5-e] indole and 7H-pyrrolo [3,2-f] quinoxaline derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands |
| EP1957486A4 (en) | 2005-11-23 | 2009-11-11 | Painceptor Pharma Corp | Compositions and methods for modulating gated ion channels |
| WO2007115409A1 (en) * | 2006-04-10 | 2007-10-18 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| EP2631229B1 (en) * | 2010-07-29 | 2014-12-03 | Nippon Chemiphar Co., Ltd. | P2x4 receptor antagonist |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK146787A (en) * | 1987-03-23 | 1988-09-24 | Ferrosan | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE |
| DK160941C (en) | 1988-06-28 | 1991-10-21 | Novo Nordisk As | CONDENSED 2,3-DIHYDROXYPYRAZINES, THEIR PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE COMPOUNDS |
| DK716188D0 (en) * | 1988-12-22 | 1988-12-22 | Ferrosan As | QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE |
| DK101290D0 (en) | 1990-04-24 | 1990-04-24 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE |
| JP2550456B2 (en) | 1990-11-06 | 1996-11-06 | 山之内製薬株式会社 | Fused pyrazine derivative |
| CA2076948C (en) | 1991-08-28 | 2002-04-16 | Frank Watjen | Isatineoxime derivatives, their preparation and use |
| AU4423496A (en) * | 1995-03-14 | 1996-10-02 | Warner-Lambert Company | Novel glutamate (ampa/kainate) receptor antagonists: n-substituted fused azacycloalkylquinoxalinediones |
-
1993
- 1993-10-08 JP JP6510172A patent/JPH08502483A/en active Pending
- 1993-10-08 AU AU51715/93A patent/AU680632B2/en not_active Ceased
- 1993-10-08 ES ES93922849T patent/ES2109516T3/en not_active Expired - Lifetime
- 1993-10-08 DK DK93922849.0T patent/DK0664807T3/en active
- 1993-10-08 EP EP93922849A patent/EP0664807B1/en not_active Expired - Lifetime
- 1993-10-08 DE DE69313866T patent/DE69313866T2/en not_active Expired - Lifetime
- 1993-10-08 AT AT93922849T patent/ATE157977T1/en active
- 1993-10-08 WO PCT/US1993/009667 patent/WO1994009000A1/en active IP Right Grant
-
1995
- 1995-05-18 US US08/443,507 patent/US6703391B2/en not_active Expired - Fee Related
-
1997
- 1997-11-05 GR GR970402894T patent/GR3025257T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2109516T3 (en) | 1998-01-16 |
| DK0664807T3 (en) | 1998-04-27 |
| US20030114422A1 (en) | 2003-06-19 |
| ATE157977T1 (en) | 1997-09-15 |
| DE69313866D1 (en) | 1997-10-16 |
| DE69313866T2 (en) | 1998-03-05 |
| AU5171593A (en) | 1994-05-09 |
| EP0664807A1 (en) | 1995-08-02 |
| WO1994009000A1 (en) | 1994-04-28 |
| US6703391B2 (en) | 2004-03-09 |
| JPH08502483A (en) | 1996-03-19 |
| AU680632B2 (en) | 1997-08-07 |
| EP0664807B1 (en) | 1997-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3025257T3 (en) | Quinoxalinedione derivatives as eaa antagonists. | |
| FI901447A0 (en) | Process for the preparation of pharmacologically active 8-substituted xanthine derivatives | |
| UA42684C2 (en) | Benzimidazolone derivatives and physiologically acceptable acid addition salts thereof | |
| PL287961A1 (en) | Method of obtaining novel tricyclic compounds | |
| ES548204A0 (en) | A METHOD FOR PREPARING A DERIVATIVE OF 1-PIPERAZIN-3-FENI- LINDANO | |
| ZA952841B (en) | Oxopyridinylquinoxaline derivative | |
| DE69526452T2 (en) | INDOLDITERPEN ALKALOIDS | |
| DE60009932D1 (en) | 5-AMINOALKYL- AND 5-AMINOCARBONYL-SUBSTITUTED INDOLE | |
| MY104630A (en) | 4(1h) ouinoline derivatives |